These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17169000)

  • 21. Chromobacterium pathogenicity island 1 type III secretion system is a major virulence determinant for Chromobacterium violaceum-induced cell death in hepatocytes.
    Miki T; Iguchi M; Akiba K; Hosono M; Sobue T; Danbara H; Okada N
    Mol Microbiol; 2010 Aug; 77(4):855-72. PubMed ID: 20545857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic variability in isolates of Chromobacterium violaceum from pulmonary secretion, water, and soil.
    Santini AC; Magalhães JT; Cascardo JC; Corrêa RX
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Closure of rRNA related gaps in the Chromobacterium violaceum genome with the PCR-assisted contig extension (PACE) protocol.
    Carraro DM; Camargo AA; Salim AC; Gonzaga L; Costa GC; Vasconcelos AT; Simpson AJ
    Genet Mol Res; 2004 Mar; 3(1):53-63. PubMed ID: 15100987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a new hemolysin from diarrheal isolate SSU of Aeromonas hydrophila.
    Erova TE; Sha J; Horneman AJ; Borchardt MA; Khajanchi BK; Fadl AA; Chopra AK
    FEMS Microbiol Lett; 2007 Oct; 275(2):301-11. PubMed ID: 17725618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of Chromobacterium sp. natural isolates from different Brazilian ecosystems.
    Lima-Bittencourt CI; Astolfi-Filho S; Chartone-Souza E; Santos FR; Nascimento AM
    BMC Microbiol; 2007 Jun; 7():58. PubMed ID: 17584942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromobacterium aquaticum sp. nov., isolated from spring water samples.
    Young CC; Arun AB; Lai WA; Chen WM; Chou JH; Shen FT; Rekha PD; Kämpfer P
    Int J Syst Evol Microbiol; 2008 Apr; 58(Pt 4):877-80. PubMed ID: 18398186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EmrR-Dependent Upregulation of the Efflux Pump EmrCAB Contributes to Antibiotic Resistance in
    Barroso KCM; Previato-Mello M; Batista BB; Batista JH; da Silva Neto JF
    Front Microbiol; 2018; 9():2756. PubMed ID: 30498484
    [No Abstract]   [Full Text] [Related]  

  • 28. The crucial amino acid residue related to inactivation of Vibrio vulnificus hemolysin.
    Senoh M; Okita Y; Shinoda S; Miyoshi S
    Microb Pathog; 2008 Jan; 44(1):78-83. PubMed ID: 17897806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microbial synthesis of violacein pigment and its potential applications.
    Park H; Park S; Yang YH; Choi KY
    Crit Rev Biotechnol; 2021 Sep; 41(6):879-901. PubMed ID: 33730942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Negative Regulation of Violacein Biosynthesis in
    Devescovi G; Kojic M; Covaceuszach S; Cámara M; Williams P; Bertani I; Subramoni S; Venturi V
    Front Microbiol; 2017; 8():349. PubMed ID: 28326068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Energetic metabolism of Chromobacterium violaceum.
    Creczynski-Pasa TB; Antônio RV
    Genet Mol Res; 2004 Mar; 3(1):162-6. PubMed ID: 15100996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chromobacterium violaceum peritonitis: case report and literature review].
    Watine J; Courtade A; Pham E; Lievrouw C; Dubourdieu B; Guérin B; Gineston JL
    Ann Biol Clin (Paris); 2006; 64(4):327-30. PubMed ID: 16829475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N9L and L9N mutations toggle Hha binding and hemolysin regulation by Escherichia coli and Vibrio cholerae H-NS.
    García J; Madrid C; Cendra M; Juárez A; Pons M
    FEBS Lett; 2009 Sep; 583(17):2911-6. PubMed ID: 19660457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromobacterium violaceum adaptation to low-phosphate conditions.
    da Costa Vasconcelos FN; Padilla G; Spira B
    Arch Microbiol; 2016 Apr; 198(3):269-77. PubMed ID: 26793969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human Chromobacterium violaceum infection in Southeast Asia: case reports and literature review.
    Jitmuang A
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):452-60. PubMed ID: 18564684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The complete genome sequence of Chromobacterium violaceum reveals remarkable and exploitable bacterial adaptability.
    Brazilian National Genome Project Consortium
    Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11660-5. PubMed ID: 14500782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel tryptophan metabolites, chromoazepinone A, B and C, produced by a blocked mutant of Chromobacterium violaceum, the biosynthetic implications and the biological activity of chromoazepinone A and B.
    Mizuoka T; Toume K; Ishibashi M; Hoshino T
    Org Biomol Chem; 2010 Jul; 8(14):3157-63. PubMed ID: 20490411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Virulence determinant of Chromobacterium violaceum].
    Miki T
    Nihon Saikingaku Zasshi; 2014; 69(4):577-88. PubMed ID: 25447983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Action and function of Chromobacterium violaceum in health and disease: Violacein as a promising metabolite to counteract gastroenterological diseases.
    Justo GZ; Durán N
    Best Pract Res Clin Gastroenterol; 2017 Dec; 31(6):649-656. PubMed ID: 29566908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Violacein: a molecule of biological interest originating from the soil-borne bacterium Chromobacterium violaceum].
    Dessaux Y; Elmerich C; Faure D
    Rev Med Interne; 2004 Sep; 25(9):659-62. PubMed ID: 15363621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.